Who owns Cellectar Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CLRB from SEC Form 13F filings across 28 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 28 institutions disclosed 4.6M shares of Cellectar Biosciences, Inc. worth $8.5M — about 26.6% of shares outstanding; the largest disclosed holder is Empery Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
28
13F holders
$8.5M
value, 2026 filers
26.6%
of shares outstanding (4.6M sh)
4
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CLRB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Empery Asset Management, LP | 955,118 | $1.8M | 1.8% | 5.5% | +403.7% |
| 2 | Stonepine Capital Management, LLC | 749,028 | $1.4M | 0.9% | 4.3% | +616.4% |
| 3 | Caligan Partners LP | 469,998 | $864,796 | 0.1% | 2.7% | 0.0% |
| 4 | Janus Henderson Group Ltd.NEW | 465,999 | $859,768 | 0.0% | 2.7% | new |
| 5 | STEMPOINT CAPITAL LP | 447,360 | $823,142 | 0.1% | 2.6% | +26.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 310,898 | $572,052 | 0.0% | 1.8% | -5.0% |
| 7 | Bleichroeder LP | 288,679 | $531,169 | 0.1% | 1.7% | 0.0% |
| 8 | Balyasny Asset Management L.P. | 220,000 | $404,800 | 0.0% | 1.3% | 0.0% |
| 9 | Nantahala Capital Management, LLC | 219,998 | $404,796 | 0.0% | 1.3% | 0.0% |
| 10 | SILVERARC CAPITAL MANAGEMENT, LLC | 151,118 | $278,057 | 0.0% | 0.9% | -53.0% |
| 11 | BOOTHBAY FUND MANAGEMENT, LLC | 85,069 | $156,527 | 0.0% | 0.5% | 0.0% |
| 12 | DIADEMA PARTNERS LP | 71,382 | $131,343 | 0.0% | 0.4% | -48.4% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 69,301 | $127,518 | 0.0% | 0.4% | +29.9% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 46,220 | $85,045 | 0.0% | 0.3% | 0.0% |
| 15 | Sequoia Financial Advisors, LLC | 32,050 | $58,972 | 0.0% | 0.2% | +46.7% |
| 16 | Persistent Asset Partners Ltd | 20,528 | $37,772 | 0.0% | 0.1% | -77.9% |
| 17 | ACADIAN ASSET MANAGEMENT LLC | 16,577 | $30,000 | 0.0% | 0.1% | 0.0% |
| 18 | NORTHERN TRUST CORP | 14,839 | $27,304 | 0.0% | 0.1% | 0.0% |
| 19 | BlackRock, Inc. | 4,735 | $8,712 | 0.0% | 0% | 0.0% |
| 20 | UBS Group AG | 3,218 | $5,921 | 0.0% | 0% | +4.0% |
| 21 | Nuveen, LLCNEW | 1,197 | $2,179 | 0.0% | 0% | new |
| 22 | MORGAN STANLEY | 500 | $920 | 0.0% | 0% | -2.0% |
| 23 | TD Waterhouse Canada Inc. | 63 | $117 | 0.0% | 0% | 0.0% |
| 24 | OSAIC HOLDINGS, INC. | 7 | $11 | 0.0% | 0% | 0.0% |
| 25 | SBI Securities Co., Ltd. | 6 | $11 | 0.0% | 0% | -45.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.